UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells

Immunity (Cambridge, Mass.), 2016-04, Vol.44 (4), p.847-859

2016

Volltextzugriff (PDF)

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9703-9711

2008

Volltextzugriff (PDF)

MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans

eLife, 2020-06, Vol.9

2020

Volltextzugriff (PDF)

The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells

The Prostate, 2014-11, Vol.74 (15), p.1530-1543

2014

Volltextzugriff (PDF)

Androgen Receptor as a Licensing Factor for DNA Replication in Androgen-Sensitive Prostate Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (41), p.15085-15090

2006

Volltextzugriff (PDF)

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

PloS one, 2010-07, Vol.5 (7), p.e11475

2010

Volltextzugriff (PDF)

DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer

Endocrine-related cancer, 2009-06, Vol.16 (2), p.325-332

2009

Volltextzugriff (PDF)

MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease

Clinical cancer research, 2018-08, Vol.24 (15), p.3668-3680

2018

Volltextzugriff (PDF)

Growth kinetics of CD133-positive prostate cancer cells

The Prostate, 2013-05, Vol.73 (7), p.724-733

2013

Volltextzugriff (PDF)

SOX2 mediates metabolic reprogramming of prostate cancer cells

Oncogene, 2022-02, Vol.41 (8), p.1190-1202

2022

Volltextzugriff (PDF)

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer

PloS one, 2013-01, Vol.8 (1), p.e53701

2013

Volltextzugriff (PDF)

Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men

Cancer research (Chicago, Ill.), 2018-11, Vol.78 (21), p.6134-6145

2018

Volltextzugriff (PDF)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review

Asian Journal of Urology, 2020-07, Vol.7 (3), p.191-202

2020

Volltextzugriff (PDF)

Syntaxin 6‐mediated exosome secretion regulates enzalutamide resistance in prostate cancer

Molecular carcinogenesis, 2020-01, Vol.59 (1), p.62-72

2020

Volltextzugriff (PDF)

Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells

Biochemical and biophysical research communications, 2018-05, Vol.499 (4), p.1004-1010

2018

Volltextzugriff (PDF)

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

Oncotarget, 2016-05, Vol.7 (18), p.26259-26274

2016

Volltextzugriff (PDF)

Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells

Molecular cancer therapeutics, 2009-05, Vol.8 (5), p.1340-1349

2009

Volltextzugriff (PDF)

Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation

International journal of biological sciences, 2014-01, Vol.10 (6), p.627-642

2014

Volltextzugriff (PDF)

Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13), p.4123-4133

2013

Volltextzugriff (PDF)

HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions

Genes & diseases, 2017-06, Vol.4 (2), p.75-87

2017

Volltextzugriff (PDF)

The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

Cancers, 2023-12, Vol.16 (1), p.10

2023

Volltextzugriff (PDF)

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

Journal of translational medicine, 2014-11, Vol.12 (1), p.313-313, Article 313

2014

Volltextzugriff (PDF)

Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (17), p.8598-8607

2006

Volltextzugriff (PDF)

The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2264-2270

2006

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells

MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans

The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells

Androgen Receptor as a Licensing Factor for DNA Replication in Androgen-Sensitive Prostate Cancer Cells

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer

MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease

Growth kinetics of CD133-positive prostate cancer cells

SOX2 mediates metabolic reprogramming of prostate cancer cells

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer

Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review

Syntaxin 6‐mediated exosome secretion regulates enzalutamide resistance in prostate cancer

Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells

Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation

Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing

HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions

The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells

The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma

Suchergebnisse filtern